Potential R&D collaboration - Walgreens Boots Alliance

Type: Research Collaboration at Walgreens Boots Alliance

About Walgreens Boots Alliance: Walgreens Boots Alliance, Inc. is an American-British-Swiss holding company headquartered in Deerfield, Illinois that owns the retail pharmacy chains Walgreens and Boots, as well as several pharmaceutical manufacturing and distribution companies. The company was formed on December 31, 2014, after Walgreens purchased the 55% stake in Alliance Boots that it did not already own. The total price of the acquisition was $4.9 billion in cash and 144.3 million common shares with fair value of $10.7 billion. Walgreens had previously purchased 45% of the company for $4.0 billion and 83.4 million common shares in August 2012 with an option to purchase the remaining shares within three years. Walgreens became a subsidiary of the newly created company after the transactions were completed. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings of the largest United States corporations by total revenue.In fiscal year 2022, the company saw sales of $132.7 billion, up 0.1% from fiscal 2021, and saw net earnings increase to $4.3 billion. The combined business has operations in 9 countries, as of August 31, 2022. Walgreens had formerly operated solely within the United States and its territories, while Alliance Boots operated a more multinational business.The company began trading on the NASDAQ on December 31, 2014, under the symbol WBA. On June 26, 2018, Walgreens Boots Alliance replaced General Electric on the Dow Jones Industrial Index. The company is also a component of the Nasdaq-100, the S&P 100 and the S&P 500 indices.
Earliest Start Date:
2nd Feb, 2023
Contacts:
Unicircles Rating:
(Ranked #8, 0 votes)
Position Expiring:
11th Mar 2025